Illinois Hospital Report Card

and Consumer Guide to Health Care

Rush University Medical Center

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than the national average or performing at the best possible rate

Not statistically significantly better or worse than the national average

Statistically significantly worse than the national average

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2024 - Q4 2024 Result 3 infections, 158839 patient days Rating SIR: 0.37	3 infections, 158839 patient days	0.37
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 11 infections, 158342 patient days Rating SIR: 1.15	11 infections, 158342 patient days	1.15
Q1 2022 - Q4 2022 Result 10 infections, 156953 patient days Rating SIR: 1.28	10 infections, 156953 patient days	1.28
Q1 2021 - Q4 2021 Result 8 infections, 160965 patient days Rating SIR: 1.04	8 infections, 160965 patient days	1.04
Q1 2020 - Q4 2020 Result 12 infections, 157040 patient days Rating SIR: 1.60	12 infections, 157040 patient days	1.60
Q1 2019 - Q4 2019 Result 5 infections, 161796 patient days Rating SIR: 0.65	5 infections, 161796 patient days	0.65
Q1 2018 - Q4 2018 Result 11 infections, 159640 patient days Rating SIR: 1.28	11 infections, 159640 patient days	1.28
Q1 2017 - Q4 2017 Result 8 infections, 154169 patient days Rating SIR: 0.89	8 infections, 154169 patient days	0.89
Q1 2016 - Q4 2016 Result 4 infections, 158229 patient days Rating SIR: 0.52	4 infections, 158229 patient days	0.52
Q1 2015 - Q4 2015 Result 8 infections, 163565 patient days Rating SIR: 0.66	8 infections, 163565 patient days	0.66
Q1 2014 - Q4 2014 Result 8 infections, 178175 patient days Rating SIR: 0.53	8 infections, 178175 patient days	0.53
Q1 2013 - Q4 2013 Result 5 infections, 172248 patient days Rating SIR: 0.35	5 infections, 172248 patient days	0.35
Q1 2012 - Q4 2012 Result 10 infections, 179167 patient days Rating SIR: 0.70	10 infections, 179167 patient days	0.70
Q1 2012 - Q2 2012 Result 6 infections, 90361 patient days Rating SIR: 0.66	6 infections, 90361 patient days	0.66
Clostridioides difficile infections (CDI) Q1 2024 - Q4 2024 Result 63 infections, 138502 patient days Rating SIR: 0.57	63 infections, 138502 patient days	0.57
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2023 - Q4 2023 Result 58 infections, 136271 patient days Rating SIR: 0.53	58 infections, 136271 patient days	0.53
Q1 2022 - Q4 2022 Result 58 infections, 139063 patient days Rating SIR: 0.54	58 infections, 139063 patient days	0.54
Q1 2021 - Q4 2021 Result 84 infections, 143160 patient days Rating SIR: 0.73	84 infections, 143160 patient days	0.73
Q1 2020 - Q4 2020 Result 65 infections, 139049 patient days Rating SIR: 0.59	65 infections, 139049 patient days	0.59
Q1 2019 - Q4 2019 Result 53 infections, 142270 patient days Rating SIR: 0.46	53 infections, 142270 patient days	0.46
Q1 2018 - Q4 2018 Result 69 infections, 144286 patient days Rating SIR: 0.61	69 infections, 144286 patient days	0.61
Q1 2017 - Q4 2017 Result 131 infections, 138139 patient days Rating SIR: 1.16	131 infections, 138139 patient days	1.16
Q1 2016 - Q4 2016 Result 142 infections, 141808 patient days Rating SIR: 1.29	142 infections, 141808 patient days	1.29
Q1 2015 - Q4 2015 Result 138 infections, 149707 patient days Rating SIR: 1.04	138 infections, 149707 patient days	1.04
Q1 2014 - Q4 2014 Result 148 infections, 161317 patient days Rating SIR: 1.09	148 infections, 161317 patient days	1.09
Q1 2013 - Q4 2013 Result 176 infections, 159512 patient days Rating SIR: 1.22	176 infections, 159512 patient days	1.22
Q1 2012 - Q4 2012 Result 154 infections, 161514 patient days Rating SIR: 1.05	154 infections, 161514 patient days	1.05